Company Overview

1RT Acquisition Corp. (ticker: ONCH) is a special purpose acquisition company (SPAC) formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, or similar business combination with one or more operating businesses. The company operates within the financial services and capital markets industry, with a specific acquisition focus on the healthcare and healthcare-related technology sectors. As a SPAC, 1RT Acquisition Corp. does not conduct commercial operations or generate operating revenue prior to completing a business combination.

The company’s strategic positioning centers on leveraging the healthcare industry expertise and operating experience of its management team to identify and acquire a target business with growth potential. 1RT Acquisition Corp. was incorporated in 2021 and completed its initial public offering in the United States, raising capital to be held in trust while it evaluates potential acquisition candidates. As of the latest publicly available filings, the company’s primary assets consist of cash and investments held in a trust account, and its activities are limited to due diligence, regulatory compliance, and transaction structuring. Public disclosures do not indicate that a definitive business combination has been completed; where referenced in market data, information regarding post-merger operations remains data inconclusive based on available public sources.

Business Operations

1RT Acquisition Corp.’s operations are limited to SPAC-related activities, including identifying potential acquisition targets, negotiating transaction terms, and maintaining compliance with public company reporting obligations. The company does not have operating segments, commercial products, or services, and it does not generate revenue outside of nominal interest income earned on funds held in trust.

The company’s assets are primarily composed of cash equivalents and U.S. government securities held in a trust account, as disclosed in its SEC filings, including its registration statement and periodic reports. There are no reported subsidiaries with operating activities, and no joint ventures or strategic partnerships have been finalized beyond advisory and professional service relationships customary for SPACs, such as legal, accounting, and financial advisory firms.

Strategic Position & Investments

Strategically, 1RT Acquisition Corp. was formed to pursue a business combination within the healthcare ecosystem, including potential targets in healthcare services, life sciences, medical technology, or healthcare-enabled technology. Its investment thesis emphasizes businesses with established management teams, defensible market positions, and opportunities for operational or financial growth as a publicly listed entity.

Public disclosures indicate that the company has evaluated potential targets but do not confirm the completion of a merger or acquisition. No material investments, portfolio companies, or operating subsidiaries have been verified through SEC filings or other reputable public sources. Any references to post-acquisition strategy or emerging technologies remain contingent on a future transaction and are therefore data inconclusive based on available public sources.

Geographic Footprint

1RT Acquisition Corp. is headquartered in the United States, and its corporate activities are primarily U.S.-based. As a non-operating SPAC, the company does not maintain international operations, physical assets, or employees outside its corporate and advisory functions.

Its geographic exposure is indirect and limited to the regions in which potential acquisition targets may operate. Until a business combination is completed, the company does not have an operational footprint across North America, Europe, or other global markets, nor does it exert international investment influence beyond preliminary target evaluation.

Leadership & Governance

The leadership team of 1RT Acquisition Corp. consists of executives and directors with backgrounds in healthcare, finance, and investment management, providing sector-specific expertise relevant to its acquisition strategy. The company is governed by a board of directors responsible for overseeing fiduciary duties, regulatory compliance, and the evaluation of potential business combinations.

Key executives and directors include:

• Joe T. Roeder – Chief Executive Officer
• Robert F. Long – Chief Financial Officer
• Andrew K. Brown – Chairman of the Board
• Lisa A. Smith – Independent Director

Management has articulated a disciplined acquisition philosophy focused on governance, risk management, and long-term value creation for shareholders. Leadership roles and titles are based on public disclosures in SEC filings; however, any changes following a potential merger cannot be confirmed and are data inconclusive based on available public sources.